References
- World Health Organization. WHO coronavirus (COVID-19) dashboard. 2021 [ Cited 2021 1 Jun]. Available from: https://covid19.who.int/.
- Bergman SJ, Cennimo DJ, Miller MM, et al. COVID-19 treatment: investigational drugs and other therapies. Medscape; 2021 [Cited 2021 May 31]. Available from: https://emedicine.medscape.com/article/2500116-overview
- Pereira AA, de-Oliveira AA, de-Andrade PA, et al. Non-pharmacological treatments for COVID-19: current status and consensus. Res Biomed Eng. 2020 Dec 3. DOI:10.1007/s42600-020-00116-1
- US Food and Drug Administration. Emergency use authorization (EUA) 2021[Cited 2021 May 30]. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#vaccines
- World Health Organization. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2021 [Cited 2021 May 30]. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_18May2021.pdf.
- Craven J. COVID-19 vaccine tracker. regulatory affairs professional society (raps) publication. Available from 2021 Nov 12: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
- World Health Organization. More than 150 countries engaged in COVID-19 vaccine global access facility. 2020 [Cited 2021 Jun 2]. Available from: https://www.who.int/news/item/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility
- Schwarzinger M, Luchini S. Addressing COVID-19 vaccine hesitancy: is official communication the key? Lancet Public Health. 2021;6(6):E353–354.
- Eniola K, Sykes J. Four reasons for COVID-19 vaccine hesitancy among health care workers, and ways to counter them. Fam Pract Manag.[Cited 2021 May 29]. Available from https://www.aafp.org/journals/fpm/blogs/inpractice/entry/countering_vaccine_hesitancy.html.
- National Records of Scotland (NRS). Covid: three deaths in Scotland linked to vaccine. BBC. 2021 [Cited 2021 Jun 2]. Available from: https://www.bbc.com/news/uk-scotland-57173286
- Torjesen I. Covid-19: pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds. BMJ. 2021;373:n1372.
- Tyson A, Johnson C, Funk CUS. Public now divided over whether to get COVID-19 Vaccine. concerns about the safety and effectiveness of possible vaccine, pace of approval process. Pew Res Center. 2020. Cited 2021 Jun 7. Available from: https://www.pewresearch.org/science/2020/09/17/u-s-public-now-divided-over-whether-to-get-covid-19-vaccine/
- Inacio P. Quick approval given COVID vaccines raise concerns, rare disease patients say. Sickle Cell Disease News 2021 [Cited 2021 Jun 7]. Available from: https://sicklecellanemianews.com/2021/04/23/quick-approval-given-covid-vaccines-raise-concerns-rare-disease-patients-say/
- Karlsson LC, Soveri A, Lewandowsky S, et al. Fearing the disease or the vaccine: the case of COVID-19. Pers Individ Dif. 2021;172:110590.
- Kaur RJ, Dutta S, Bhardwaj P, et al. Adverse events reported from COVID-19 vaccine trials: a systematic review. Ind J Clin Biochem. 2021;36(4):427–439.
- Beusekom MV. Data reveal fewer real-world COVID vaccine side effects. Center for infectious Disease Research and Policy. 2021 [Cited 2021 June 7]. Available from: https://www.cidrap.umn.edu/news-perspective/2021/04/data-reveal-fewer-real-world-covid-vaccine-side-effects
- Health and Safety Executive. Safety update: vaxzevria (COVID-19 vaccine AstraZeneca) and COVID-19 vaccine Janssen 2021 [Cited 2021 Jun 7]. Available from.https://www.hse.ie/eng/health/immunisation/hcpinfo/covid19vaccineinfo4hps/astrazeneca/azqnda.pdf
- Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–1090.
- Paulsen F, Schaefers C, Langer F, et al. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood. 2021;138(11):996–999.
- Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood J Am Soc Hematol. 2021;138(4):293–298.
- Center for Disease Control and Prevention-Wonder. The vaccine adverse event reporting system (VAERS) 2021 [Cited 2021 May 26]. Available from: http://wonder.cdc.gov/vaers.html
- US Food and Drug Administration. Janssen COVID-19 vaccine EUA fact sheet for healthcare providers 2021 [Cited 2021 May 26]. Available from: https://www.fda.gov/media/146304/download
- Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101–1102.
- COVID-19 Vaccine (adenovirus vector). Lexicomp online database [database on the internet]. Hudson (OH): Lexicomp Inc. publication year 2021; cited Nov 24. Available from. http://online.lexi.com
- Garcıa-Azorın D. FACME ad-hoc working group. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologıa. 2021;36(6):451–461.
- Mehta PR, Apap-Mangion S, Benger M, et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases. Brain Behav Immun. 2021;95:514–517.
- US Food and Drug Authority. Moderna COVID-19 Vaccine EUA fact sheet for health care providers 2021 [Cited 2021 May 26]. Available from: https://www.fda.gov/media/144637/download
- US Food and Drug Authority. Pfizer-BioNTech COVID-19 vaccine EUA fact sheet for healthcare providers 2021 [Cited 2021 May 26]. Available from: https://www.fda.gov/media/144413/download
- AstraZeneca. COVID-19 AstraZeneca vaccine analysis print 2021 [Cited 2021 June 7]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/990932/COVID-19_AstraZeneca_Vaccine_Analysis_Print_26.05.2021.pdf
- Feuerstein A. Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says. Stat news. 2020 [Cited 2021 Jun 7]. Available from: https://www.statnews.com/2020/09/09/astrazeneca-covid19-vaccine-trial-hold-patient-report/
- Package leaflet: information for the user interim authorization COVID-19 Vaccine Moderna dispersion for injection: moderna biotech 2021 [Cited 2021 Jun 2]. Available from https://www.hsa.gov.sg/docs/default-source/hprg-tpb/guidances/covid-19-vaccine-moderna-sg-pil.pdf
- Jeong M. Pfizer vaccine for COVID-19: what are the side effects? Medical News Today 2021 [Cited 2021 Jun 8]. Available from.;https://www.medicalnewstoday.com/articles/pfizer-vaccine-for-covid-19-what-are-the-side-effects
- US Food and Drug Authority. Fact sheet for recipients and caregivers 2021 [Cited 2021 Jun 7]. Available from: https://www.fda.gov/media/144414/download
- Blumenthal KG, Robinson LB, Camargo CA, et al. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA. 2021;325(15):1562–1565.
- Miller K. Is heart inflammation a side effect of the COVID vaccine? CDC Is studying reports of myocarditis in young people. Health. 2021. Cited 2021 Jun 7. Available from: https://www.health.com/condition/infectious-diseases/coronavirus/pfizer-vaccine-heart-inflammation-myocarditis
- Heart inflammation probed as possible rare Covid vaccine side effect in teens, young adults. The Economic Times. 2021 [Cited 2021 Jun 5]. Available from: https://economictimes.indiatimes.com/magazines/panache/heart-inflammation-probed-as-possible-rare-covid-vaccine-side-effect-in-teens-young-adults/articleshow/83228841.cms
- Mandavilli ACDC. Is investigating a heart problem in a few young vaccine recipients? The New York Times. 2021 [Cited 2021 Jun 4]. Available from:https://www.nytimes.com/2021/05/22/health/cdc-heart-teens-vaccination.html
- Buntz B. Tinnitus reports grow amid COVID-19 vaccinations.drug discovery and development 2021 [Cited 2021 May 25]. Available from: https://www.drugdiscoverytrends.com/tinnitus-reports-grow-amid-covid-19-vaccinations/
- Jeong M. Moderna COVID-19 vaccine: what to know about side effects. Medical News Today. 2021 [Cited 2021 May 19]. Available from: https://www.medicalnewstoday.com/articles/moderna-covid-19-vaccine-what-to-know-about-side-effects
- Schraer R. Covid vaccine: sore arm and headache most common side effects. BBC. 2021 [Cited 2021 May 5]. Available from: https://www.bbc.com/news/health-56901356
- Centers for Disease Control and Prevention. Allergic reactions including anaphylaxis after receipt of the first dose of moderna COVID-19 vaccine–United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):125–129.
- Launder M. Fatigue and headache ‘most common Covid vaccine side effects’ Pulse 2021 Cited 2021 May 21]. Available from https://www.pulsetoday.co.uk/news/clinical-areas/pain/fatigue-and-headache-most-common-covid-vaccine-side-effects/
- Martin V. Ask the expert: the COVID-19 vaccination and headache. National Headache Foundation. 2021 [Cited 2021 May 19]. Available from: https://headaches.org/2021/03/24/ask-the-expert-covid-19-vaccination-and-headache/
- COVID-19 vaccination guidelines for clinical immunology/allergy specialists. ASCIA. 2021 Cited 2021 Nov 17]. Available from https://www.allergy.org.au/hp/papers/guide-covid-19-vaccination
- What are the side effects of the Pfizer vaccine? Open Access Government. 2021 [Cited 2021 Jun 19]. Available from: https://www.openaccessgovernment.org/what-are-the-side-effects-of-the-pfizer-vaccine/104380/
- Bussel JB, Connors JM, Cines DB. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia. version 1.2. American Society of Hematology. 2021 [Cited 2021 May 29]. Available from: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
- Shapiro N. Study looks at link between Covid-19 vaccine and sudden hearing loss. Forbes 2021. https://www.forbes.com/sites/ninashapiro/2021/05/23/study-looks-at-link-between-covid-19-vaccine-and-sudden-hearing-loss/?sh=7ce744e75a81. Cited 2021 May 25]. Available from
- Centers for Disease Control and Prevention. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States. 2020 Dec 14–23. MMWR Early Release. 2021; 70(2):46–51. Available from. https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm?s_cid=mm7002e1_w
- Walker MACIP. No rise in anaphylaxis rates after COVID Vax. Medpage Today. 2021 Cited 2021 Nov 17]. Available from https://www.medpagetoday.com/infectiousdisease/covid19/90919
- Centers for Disease Control and Prevention. Allergic reactions including anaphylaxis after receipt of the first dose of moderna COVID-19 vaccine - United States, December 21, 2020–January 10, 2021. MMWR Early Release. 2021; 70(4):125–129. Available from https://www.cdc.gov/mmwr/volumes/70/wr/mm7004e1.htm?s_cid=mm7004e1_w
- Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med. 2021;384(7):643–649.
- Caballero ML, Quirce S. Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of currently authorized COVID-19 vaccines. J Investig Allergol Clin Immunol. 2021;31(1):92–93.
- Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101.
- Taquet M, Husain M, Geddes JRet al. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. medRxiv. 2021.39.101061. DOI:10.1016/j.eclinm.2021.101061
- Pavord S, Scully M, Hunt BJ, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021;385(18):1680–1689.
- Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.
- ACAAI updates to guidance on risk of allergic reactions to Covid-19 vaccines. American College of Allergy, Asthma & Immunology. 2021 [Cited 2021 May 11]. Available from: https://acaai.org/news/acaai-updates-guidance-risk-allergic-reactions-covid-19-vaccines
- Sellaturay P, Nasser S, Ewan P. Polyethylene Glycol–induced systemic allergic reactions (Anaphylaxis). J Allergy Clin Immunol Pract. 2021;9(2):670–675.
- Wylon K, Dölle S, Worm M. Polyethylene glycol as a cause of anaphylaxis. Allergy Asthma Clin Immunol. 2016;12(1):67.
- Hibbs BF, Miller E, Shi J, et al. Safety of vaccines that have been kept outside of recommended temperatures: reports to the Vaccine Adverse Event Reporting System (VAERS), 2008–2012. Vaccine. 2018;36(4):553–558.
- Tang AW. A practical guide to anaphylaxis. Am Fam Physician. 2003;68(7):1325–1332.
- Bousquet J, Agache I, Blain H, et al. Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021;76(10):2952–2964.
- Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hämostaseologie. 2021;41(3):184–189.
- Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83(6):719–724.
- Squires JE. Indications for platelet transfusion in patients with thrombocytopenia. Blood Transfus. 2015;13(2):221–226.
- Warkentin TE, Cuker A. COVID-19: vaccine-induced immune thrombotic thrombocytopenia (VITT). Uptodate. 2021 Cited 2021 Nov 17]. Available from https://www.uptodate.com/contents/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt#H364190061
- Su JR. Myopericarditis following COVID-19 vaccination: updates from the vaccine adverse event reporting system (VAERS).2021 CDC [Cited 2021 Nov 17] Available from https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-08-30/03-COVID-Su-508.pdf
- COVID-19 vaccines while pregnant or breastfeeding. CDC. 2021 [Cited 2021 May 23]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
- Berghella V, Hughes B. COVID-19: pregnancy issues and antenatal care. Up to Date. 2021 [Cited 2021 May 29]. Available from.https://www.uptodate.com/contents/covid-19-pregnancy-issues-and-antenatal-care/print?search=coronavirus-disease-2019-covid-19-pregnancy-issues%3E%26source=search_result%26selectedTitle=1~150%26usage_type=default%26display_rank=1.
- Information for pediatric healthcare providers. CDC. 2020 [Cited 2021 Jun 9]. Available from:https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html
- Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents. Pfizer. 2021 [Cited 2021 May 7]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-announce-positive-topline-results-pivotal
- Ghosh P. When to take Covid-19 vaccine after recovery? wait for 3 months, says centre. Hindustan Times. 2021 [Cited 2021 May 24]. Available from: https://www.hindustantimes.com/india-news/vaccination-3-months-after-recovery-from-covid-19-says-health-ministry-101621421679394.html
- Frequently asked questions about COVID-19 vaccination. CDC. 2021 [Cited 2021 Jun 19]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html
- COVID-19 vaccine reported allergic reactions. Allergy and Asthma Network. 2021 [Cited 2021 May 21]. Available from: https://allergyasthmanetwork.org/news/statement-on-covid-vaccine/
- Erskine D. Using COVID-19 vaccines in patients with anticoagulation and bleeding disorders. Specialist Pharmacy Service. 2021 [Cited 2021 Jun 11]. Available from: https://www.sps.nhs.uk/articles/using-covid-19-vaccines-in-patients-with-anticoagulation-and-bleeding-disorders/
- Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine. Newsroom. 2021 [Cited 2021 May 9]. Available from: https://newsroom.heart.org/news/guidance-on-treatment-for-rare-blood-clots-and-low-platelets-related-to-covid-19-vaccine
- People with certain medical conditions. CDC. 2021 [Cited 2021 May 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
- Ferretti F, Cannatelli R, Benucci M, et al. How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: an expert opinion by IMIDs study group. Front Immunol. 2021;12:656362.
- Dougados M. Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic. The Lancet Rheumatology. 2021;3(6):e395–e396.
- Rahav G, Lustig Y, Lavee J, et al. BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: a prospective cohort study. E Clinical Medicine. 2021;41. 101158.
- Levy I, Wieder-Finesod A, Litchevsky V, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021;27(12):S1198-743X(21)00423–7.
- Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385(7):661–662.
- COVID-19 vaccine safety surveillance. [Cited 2021 Nov 17]. Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/covid-19-vaccine-safety-surveillance
- Law B. SO2-D2.1.2 priority list of COVID-19 adverse events of special interest: quarterly update December 2020. SPEAC. 2020 Cited 2021 Nov 17]. Available from https://brightoncollaboration.us/wp-content/uploads/2021/01/SO2_D2.1.2_V1.2_COVID-19_AESI-update-23Dec2020-review_final.pdf